The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy - Wikidata - awgldk - TriplyDB

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

http://www.wikidata.org/entity/Q35180377

about

Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India.Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients.Mycophenolate versus Cyclophosphamide for Lupus Nephritis.

P2860

Q36752458-00CD03A2-1B67-4ABF-90E5-BA40912E37D1 Q49618000-F04A57C0-669A-429E-8BE0-1CDC04B9BFF6 Q54260329-C250EA32-40F4-41B9-869A-F4B0BAA59942

P2860

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

http://www.wikidata.org/entity/Q35180377

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@ast

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@en

type

label

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@ast

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@en

prefLabel

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@ast

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@en

P1433

Q35180377-E2C4B204-6445-4EAC-A795-EF7A545A3038

P1476

Q35180377-CDB74B72-7960-418E-96F9-B892AEE0BE95

P2093

Q35180377-3B670FF6-1FDB-48EB-85D6-EE8524198925

Q35180377-5F1F66D6-38F8-4C06-9EA5-B72DB3B8677B

Q35180377-91A34F05-1E62-45EB-95B3-28FAD5679802

Q35180377-92355F66-FB05-4B39-9274-C6B086F86844

Q35180377-ED33D132-F8BD-47C4-AC16-BBA61F1D8B27

Q35180377-FBF6BCBB-746B-454F-8825-CF50ACB2E041

P2860

Q35180377-03FF084C-AC08-4516-85AF-09FC9DFF26A4

Q35180377-24D72CE1-9363-477A-9A9B-E7AA24EC9A00

Q35180377-4973F44F-E7D4-4996-82D2-A3A1B8F4F4A3

Q35180377-5C1CD2D8-2DC2-4E6E-9304-7588827FA831

Q35180377-6E222F4C-5E18-47EB-8AEC-9429C493AC83

Q35180377-7BCCC240-72C9-47A9-A8A7-3FB5751322D2

Q35180377-7D0F03CB-0D82-47B1-A3E6-25ACDFAFF515

Q35180377-AA2847F6-E717-4FAA-B63D-443C2E54B895

Q35180377-C81E0575-F517-4CB8-A08B-D06145BF0792

Q35180377-CED10F6E-94E1-4DF9-AF38-EAA379688A76

P304

Q35180377-67AD98B5-3FA0-4A90-89B7-5B5B8AC06858

P31

Q35180377-DE42002E-2A24-43EE-BDB0-CBA0AAD7C094

P356

Q35180377-22D9017E-5BE1-45E9-AB4F-320B67F887AB

P433

Q35180377-53857B41-43E1-449B-9A81-6940E278AC09

P478

Q35180377-88E207F4-7E89-4A37-BA63-CEA5F2CDF666

P577

Q35180377-BA423FF1-54CD-41F6-8F34-E6CFAF0DEE21

P698

Q35180377-EC5E0EF4-B4D1-4233-829D-E3A09B3F1B14

P932

Q35180377-11D537D2-20D9-41B4-9847-3C2A62F0B89B

P356

0971-4065.83933

P1433

Indian Journal of Nephrology

P1476

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy

@en

P2093

A Prayaga

http://www.w3.org/2001/XMLSchema#string

C A Narain

http://www.w3.org/2001/XMLSchema#string

K V D Murty

http://www.w3.org/2001/XMLSchema#string

M Desai

http://www.w3.org/2001/XMLSchema#string

S K Annavarajula

http://www.w3.org/2001/XMLSchema#string

U Das

http://www.w3.org/2001/XMLSchema#string

P2860

Lupus nephritis: an historical perspective 1968-1998.

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.

Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

Severe lupus nephritis: racial differences in presentation and outcome.

Sequential therapies for proliferative lupus nephritis.

How did cyclophosphamide become the drug of choice for lupus nephritis?

Mycophenolate mofetil for lupus nephritis.

P304

160-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-4065.83933

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21886974

http://www.w3.org/2001/XMLSchema#string

P932

3161432

http://www.w3.org/2001/XMLSchema#string